Sk Biopharmaceuticals Co., Ltd. (326030)
KRX
Closed
Aug 26, 2026
Day's Range
84,800.0052 wk Range
73,000.00Overview - 326030 - Sk Biopharmaceuticals Co., Ltd.
Key Statistics
Valuation
Enterprise Value
6.43T
P/E (Trailing)
‪26.87‬
P/E (Forward)
‪17.48‬
PEG Ratio
‪0.07‬
Price / Sales (TTM)
‪7.85‬
Price / Book
‪7.69‬
EV / EBITDA
‪20.16‬
Profitability
Gross Margin
‪93.71%‬
Profit Margin
‪46.55%‬
Operating Margin
‪39.23%‬
Return on Assets
‪15.98%‬
Return on Equity
‪47.91%‬
Ownership
Shares Outstanding
78.31M
Float
39.03M
Held by Insiders
‪50.17%‬
Held by Institutions
‪12.52%‬
Price stats
Beta
‪0.72‬
50-Day Avg
‪83,734.00‬
200-Day Avg
‪104,653.00‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
12 analysts
Average price target
‪₩ 128,666.66‬Market Cap - 326030 - Sk Biopharmaceuticals Co., Ltd.
Peers - 326030 - Sk Biopharmaceuticals Co., Ltd.
Peer Comparison
Compared with companies in Biotechnology listed on KRX.
- 326030KRXSk Biopharmaceuticals Co., Ltd.6.76TMarket Cap-16.32%52-week change25.34P/E (Trailing)‪44.13%‬Profit Margin
- 207940KRXSamsung Biologics Co., Ltd.73.37TMarket Cap+1.05%52-week change59.52P/E (Trailing)‪38.74%‬Profit Margin
- 068270KRXCelltrion Inc.43.48TMarket Cap+14.21%52-week change42.65P/E (Trailing)‪32.18%‬Profit Margin
- 196170KRXALTEOGEN Inc.21.25TMarket Cap-6.51%52-week change149.70P/E (Trailing)‪63.89%‬Profit Margin
- 0126Z0KRXSamsung Epis Holdings Co., Ltd.9.16TMarket Cap-19.00%52-week change—P/E (Trailing)‪33.89%‬Profit Margin
- 028300KRXHLB Co., Ltd.5.08TMarket Cap+1.04%52-week change-22.80P/E (Trailing)‪-228.04%‬Profit Margin
- 214450KRXPharma Research Products Co., Ltd4.30TMarket Cap-69.84%52-week change26.08P/E (Trailing)‪31.21%‬Profit Margin
Profile Summary - 326030 - Sk Biopharmaceuticals Co., Ltd.
About
Sk Biopharmaceuticals Co., Ltd. is a leading biomedical company primarily engaged in the research, development, and commercialization of innovative pharmaceutical products. This company operates with a strong focus on central nervous system (CNS) disorders, aiming to address unmet medical needs through its proprietary…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
